Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02138396 · ClinicalTrials.gov registry record · NA
Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions
A NA study, sponsored by INSYS Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02138396 is a NA study that has completed, run by INSYS Therapeutics. The registered enrollment target is 12 participants.
The verdict
NCT02138396, a NA study, has completed, sponsored by INSYS Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The objective of this study is to compare the rate of absorption and bioavailability of fentanyl sublingual spray 400 mcg to fentanyl citrate 100 mcg by intramuscular injection.
Interventions
- DRUG Naltrexone
- DRUG Fentanyl Sublingual Spray (FSS)
- DRUG Fentanyl Citrate Injection (FCI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02138396
The ClinicalTrials.gov registry entry for NCT02138396 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is INSYS Therapeutics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Naltrexone is the first listed.
NCT02138396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02138396 about?
NCT02138396 is a clinical study titled "Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions". The objective of this study is to compare the rate of absorption and bioavailability of fentanyl sublingual spray 400 mcg to fentanyl citrate 100 mcg by intramuscular injection.
What is the current status of trial NCT02138396?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2014-01. Estimated completion is 2014-01.
What interventions are being tested in trial NCT02138396?
The interventions under investigation include: Naltrexone (DRUG), Fentanyl Sublingual Spray (FSS) (DRUG), Fentanyl Citrate Injection (FCI) (DRUG).
Who is sponsoring clinical trial NCT02138396?
This trial is sponsored by INSYS Therapeutics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.